C07D 239/70
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D239/70 (Condensed with carbocyclic rings or ring systems) appears on 2,711 US grants and 2,808 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,711
- Published applications
- 2,808
- Assignees
- 1,203
- Inventors
- 8,733
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 18 | 0 |
| 1978 | 28 | 0 |
| 1979 | 21 | 0 |
| 1980 | 23 | 0 |
| 1981 | 19 | 0 |
| 1982 | 27 | 0 |
| 1983 | 20 | 0 |
| 1984 | 31 | 0 |
| 1985 | 21 | 0 |
| 1986 | 25 | 0 |
| 1987 | 32 | 0 |
| 1988 | 24 | 0 |
| 1989 | 23 | 0 |
| 1990 | 15 | 0 |
| 1991 | 14 | 0 |
| 1992 | 19 | 0 |
| 1993 | 34 | 0 |
| 1994 | 32 | 0 |
| 1995 | 32 | 0 |
| 1996 | 25 | 0 |
| 1997 | 34 | 0 |
| 1998 | 63 | 0 |
| 1999 | 56 | 0 |
| 2000 | 41 | 0 |
| 2001 | 59 | 16 |
| 2002 | 69 | 60 |
| 2003 | 53 | 81 |
| 2004 | 40 | 119 |
| 2005 | 39 | 146 |
| 2006 | 70 | 106 |
| 2007 | 64 | 120 |
| 2008 | 51 | 115 |
| 2009 | 58 | 131 |
| 2010 | 88 | 163 |
| 2011 | 92 | 126 |
| 2012 | 96 | 105 |
| 2013 | 121 | 115 |
| 2014 | 119 | 128 |
| 2015 | 118 | 138 |
| 2016 | 102 | 130 |
| 2017 | 123 | 121 |
| 2018 | 91 | 114 |
| 2019 | 108 | 116 |
| 2020 | 94 | 118 |
| 2021 | 69 | 85 |
| 2022 | 62 | 102 |
| 2023 | 57 | 123 |
| 2024 | 55 | 104 |
| 2025 | 60 | 77 |
| 2026 | 44 | 49 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-y1]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate monohydrate, its preparation and use22 Sep 2026US 12,741,943 B2AIC246 AG & Co. KG
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Quinazoline-4(3H)-one derivatives as negative allosteric modulators of metabotropic glutamate receptor 225 Aug 2026US 12,715,879 B2Vanderbilt University
- Crystalline form, and process for its production11 Aug 2026US 12,703,688 B1Alterity Therapeutics Limited
- Protein kinase inhibitors and uses thereof1 Oct 2026US 2026/0297035 A1DELiver Therapeutics, Inc.
- Precipitation process for amorphous letermovir1 Oct 2026US 2026/0297036 A1Lupin Limited
- Compound comprising n-methylpiperazine ethanol carbamate structure and use thereof1 Oct 2026US 2026/0297037 A1Korea Institute of Radiological & Medical Sciences
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Piperazinyl-Modified Quinazolinyl-Aryl Urea Derivative, And Preparation Method And Use Thereof24 Sep 2026US 2026/0285816 A1Guangxi Normal University
Most cited
By later US patents
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Quinazoline derivatives217US 5,770,599 AZeneca Limited · 1998
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995